Patent
Lilly challenging Biogen patent in London lawsuit
January 5, 2012
Bloomberg NewsEli Lilly and Co. has sued Biogen Idec Inc. in a London court to revoke a European patent on a potential treatment for immune-system
diseases.
MorePatent expirations up pressure on Lilly
December 24, 2011
Eli Lilly and Co. lost patent protection on its $5-billion-a-year best-seller Zyprexa in October, plunging the company into
the long-awaited zone of uncertainty that it calls “Years YZ.”
MoreJONES: Patent reform is mixed bag for life sciences companies
November 26, 2011
Kristin Jones / Special to IBJFor Indiana's life sciences sector, the change both raises hopes and creates challenges for continued growth.
MoreLilly files suit over flea medication sales from Australia
November 11, 2011
Scott OlsonThe Indianapolis-based pharmaceutical firm claims an Australian veterinary clinic is infringing on its Comfortis flea medication's
trademark by reselling it to U.S. consumers online.
MoreBorgWarner sues Cummins over patents on turbochargers
October 27, 2011
Bloomberg NewsBorgWarner Inc., the world’s biggest maker of automatic-transmission parts for vehicles, filed a lawsuit accusing Cummins
Inc. of infringing on three patents for a titanium wheel used in engine turbochargers.
MoreZyprexa era comes to an end for Lilly
October 27, 2011
IBJ StaffOn Oct. 24, the U.S. Food and Drug Administration approved the first generic versions of Eli Lilly and Co.’s best-seller,
ending 15 years of highly lucrative sales.
MoreLilly: Vendors key after Zyprexa patent loss
October 24, 2011
J.K. WallLilly's patent-loss challenges—the biggest of which takes effect today—will force the company to rely even more
on its 1,300 Indiana vendors.
MoreSenate passes overhaul of patent system
September 10, 2011
Bloomberg NewsThe legislation would fundamentally alter the way patents are reviewed and mark the biggest change to U.S. patent law since
at least 1952.
MoreDespite sales spike, Effient has middling prospects
July 25, 2011
J.K. WallRemember Effient? The blood thinner that was once Eli Lilly and Co.’s greatest post-Zyprexa hope and then, after a slow
launch, was dismissed as an abject failure? Well, it’s turning out to defy both predictions.
MoreLilly CEO: Immigration, tax laws slow innovation
June 23, 2011
Bloomberg NewsThe U.S. government needs to open its borders to attract and retain talented scientists for drugmakers to employ, Eli Lilly
& Co. CEO John Lechleiter plans to tell a technology conference Thursday.
MoreGrowth in drug spending to slow as generics rise
May 18, 2011
Bloomberg NewsThe annual growth rate in spending on drugs may be cut in half over the next five years as people opt for less expensive generic
medicines over brand-name treatments, a health-care research group said Wednesday, highlighting the challenge pharmaceutical
firms like Eli Lilly and Co. are facing.
MoreZimmer, peer sued over arthritic-knee treatments
April 26, 2011
Bloomberg NewsGenzyme Corp., the drugmaker bought by Sanofi-Aventis SA this month, sued Zimmer Holdings Inc. and Anika Therapeutics Inc.
alleging the companies’ treatments for arthritic knee pain infringe a patent.
MoreFirm joins race with IU autism drug
April 9, 2011
J.K. WallThe Indiana University School of Medicine has licensed a pediatric psychiatrist's patent on
an alcohol-dependency drug that the doctor discovered improves the language and social skills of autism patients. IU has licensed
the patent to Indianapolis-based Confluence Pharmaceuticals Inc.
MoreLechleiter: After the deluge, we'll be fine
March 16, 2011
J.K. WallEli Lilly and Co. CEO John Lechleiter visited Japan last week—three days before the massive earthquake—to deliver
his tried-and-true message: Drug companies need to reinvent invention, governments needs to support innovation, and Lilly
will be just fine after it has sustained the damage of the next three years.
MoreDow Chemical moves toward engineered corn patent
March 1, 2011
Associated PressDow Chemical Co.'s agricultural division said it has taken the next step toward gaining international patent rights for
its new strain of genetically engineered corn that it says will help farmers battle a new strain of "super-weeds."
MoreCongress takes up major change in patent law
February 28, 2011
Associated PressCongress has been trying for well over a decade to rewrite patent law, only to be thwarted by the many interested parties.
MoreIntellectual property theft rising quickly
February 26, 2011
Bob Kronemyer / Special to IBJFilching ranges from crude to highly sophisticated, experts say.
MoreEmerging markets give Lilly hope in patent crunch
February 19, 2011
J.K. WallIn a kind of alternate drug universe, sales of Eli Lilly and Co.’s ghosts of blockbusters past are soaring in China—prompting
the drugmaker to pour money into emerging markets in an attempt to prop up revenue.
MoreVanderbilt rejected by high court on Cialis patents
January 24, 2011
Bloomberg NewsSupreme Court justices on Monday left intact a ruling throwing out a lawsuit pressed by the Nashville, Tenn., university against
Eli Lilly's Icos subsidiary.
MoreEli Lilly puts faith in drug pipeline
December 24, 2010
J.K. WallEli Lilly and Co. started to tip over its massive “patent cliff” this year, yet announced little publicly that
will significantly soften its inevitable sales plunge.
MoreHillenbrand wins ban of knockoff coffins from Mexico
December 14, 2010
Bloomberg NewsThe U.S. International Trade Commission said Monday that Ataudes Aguilares will be barred from bringing in caskets with attached
memorabilia compartments, which Batesville-based Hillenbrand has patented.
MorePhase 10 inventor folds in dispute over top-selling card game
November 22, 2010
Cory SchoutenThe inventor of the world's second-best-selling card game has settled a lawsuit with Fundex Games, the Plainfield company
that markets and distributes Phase 10.
MoreLilly scores series of small victories
November 17, 2010
J.K. WallThe Indianapolis-based drugmaker finally won FDA approval for its antidepressant Cymbalta to treat chronic pain and fended
off a patent challenge to rising-star cancer drug Alimta, but got a ratings downgrade on its debt.
MoreCourt upholds Lilly patent on cancer drug Alimta
November 16, 2010
IBJ Staff and Associated PressA U.S. District Court judge on Monday upheld Eli Lilly and Co.’s patent on the cancer drug Alimta, protecting the compound
until July 2016. It was a welcome win after a difficult few months for Indianapolis-based Lilly, which is facing a wave of
patent expirations in coming years.
MoreAppeals court rejects Lilly over Gemzar patent
November 1, 2010
IBJ Staff and Bloomberg NewsWithout an appeal, generic drugs are now poised to wipe away most of Lilly's $750 million in annual U.S. revenue from Gemzar.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
IBJ Featured Advertisers
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
we love that we were right in our predictions for the outcome of Tony's boondoggle. We aren't negative, we are positive that the league that never has will continue to blow chunks and stink up the place
I was initially excited to learn that this wasn't rubber-stamped, but if all that is required is to add some shrubs and some "window dressing" over the first floor of the garage, then I'd call it a waste of everyone's time. It should be noted that the Hearing Examiner is a DMD employee who reports to the same administrator as the DMD staff planner who recommended approval of the garage and whose report said that the requirement for ground-floor retail had been "satisfied". Better luck with appealing the inevitable approval at the MDC, where the commissioners are appointed by the Mayor, City Council, and County Commissioners, thus, presumably not all obligated to facilitate the administration's plans.
Wheat Thins, when paired with chocolate ice cream!
About the same.
New airport, new Lucas Oil Stadium, expanded convention center, $30,000,000 Pacer gift, Stupid City Way Project, Broad Ripple Parking Garage $ Giveaway, Money blown on lethal bike lanes. The list is endless..
We have complete morons in City Government with grafter buddies sitting in the wings also stealing parking meter revenue. Go to www.adavceindiana.com and read about Chicago Parking Meter Corruption.
It's all theft of taxpayer resources and complete lack of financial stewardship and devoid of integrity.
I would just like for basic city services please.